BNTX

BNT162

COVID-19 Vaccine

Phase 2b/3 safety and efficacy trial Data

Exp Date

Late November 2020

Amp Volatility Score

Catalyst Info & Data Links

TITLE: BioNTech & Pfizer COVID-19 Vaccine (BNT162) Phase 2b/3 safety and efficacy trial Readout

  • Clinical trial.gov (NCT04380701): A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults


WHAT IS THE CATALYST EVENT?


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • Late November 2020 


PRIOR DATA

PRESS RELEASES

BioNTech, Pfizer, BNTX, COVID-19 vaccine, BNT162

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

BNTX - Pfizer Canada and BioNT...

BNTX "announced the initiation of a rolling submission to Health Canada for BNT162b2, the lead candidate from the companies’ vaccine development program against COVID-19.

The rolling submission has b...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon